Collegium Pharmaceutical, Inc. Financial Ratios — COLL Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-85.62	-62.65	-39.99	-25.39	19.57	36.77	-12.57	24.68	32.62	23.7
Return on Assets (%)	- -	-253.71	-53.02	-72.52	-50.32	-18.33	-7.61	5.63	10.71	-2.68	4.16	4.93	3.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	19.5	- -	- -	11.4	12.37	10.77
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	19.36	- -	- -	11.89	11.84	10.86
Gross Margin (%)	- -	- -	- -	87.55	90.89	40.92	34.73	58.01	54.4	45.15	57.55	59.76	59.35
EBITDA Margin (%)	- -	- -	- -	-5,460.37	-262.86	32.18	-2.79	37.99	32.91	37.13	55.79	53.23	51.82
Operating Margin (%)	- -	- -	- -	-5,498.66	-264.95	-7.38	-8	18.14	8.02	7.18	29.46	26.44	22.86
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	600.68	102.65	5.94	129.96	0.03	7.69
Pretax Margin (%)	- -	- -	- -	-5,504.15	-262.91	-13.95	-7.66	8.9	-1.22	-6.22	13.36	15.61	11.87
Profit Margin (%)	- -	- -	- -	-5,504.15	-262.91	-13.95	-7.66	8.63	25.83	-5.39	8.5	10.96	8.05
Net Income to Common Margin (%)	- -	- -	- -	-5,504.15	-262.91	-13.95	-7.66	8.63	25.83	-5.39	8.5	10.96	8.05
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	3.01	- -	- -	36.41	29.8	32.12
Dvd Payout Ratio (%)	15.3	15.55	-36.13	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-85.62	-62.65	-39.99	-25.39	19.57	36.77	-12.57	24.68	32.62	23.7

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	13	7	4	1	12	22	267	259	709	674	859	815
ST Debt	- -	6	3	3	1	2	4	48	49	164	184	66	30
LT Debt	1	7	4	1	- -	10	17	218	210	546	490	793	784
Total Debt/EBITDA	-0.06	-0.74	-0.25	-0.04	-0.02	0.13	-2.61	2.26	2.84	4.12	2.13	2.56	2.01
Net Debt/EBITDA	0.41	-0.65	3.32	1.6	1.57	-1.5	19.18	0.7	0.7	3.06	1.35	2.33	1.43
Total Debt/EBIT	-0.06	-0.74	-0.25	-0.04	-0.02	-0.56	-0.91	4.74	11.65	21.28	4.04	5.15	4.57
Net Debt/EBIT	0.41	-0.64	3.3	1.58	1.55	6.53	6.68	1.48	2.86	15.82	2.56	4.68	3.24
EBITDA to Interest Expense	-208.86	-69.36	-60.9	-993.9	- -	4.48	-9.09	4.08	4.34	2.73	3.79	4.54	4.91
EBITDA-CapEx/Interest Expense	-211.57	-69.39	-61.73	-1,025.57	- -	3.27	-16.17	-8.86	4.24	2.7	3.79	4.52	4.89
EBIT to Interest Expense	-211.08	-70.1	-61.29	-1,000.87	- -	-1.03	-26.13	1.95	1.06	0.53	2	2.26	2.17
Interest Expense	- -	- -	- -	- -	- -	20	1	29	21	63	83	74	82
Common Equity/Total Assets	-755.2	-1,755.36	87.06	83.27	76.77	31.45	28.54	28.89	29.32	16.59	17.09	13.76	18.21
Long-Term Debt/Equity (%)	11.47	- -	4.87	1.1	- -	10.76	19.56	117.38	103.28	280	250.71	346.72	260.03
Long-Term Debt/Capital (%)	9.76	889.43	4.51	1.06	- -	9.56	15.69	48.24	45.4	60.35	56.34	72.92	70.26
Long-Term Debt/Total Assets (%)	7.08	133.85	4.24	0.91	- -	3.38	5.58	33.92	30.28	46.47	42.85	47.69	47.35
Total Debt/Equity (%)	17.43	-106.26	8.01	3.07	1.42	12.56	24.7	143.3	127.51	363.97	345.02	375.5	270.11
Total Debt/Capital (%)	14.84	1,698.04	7.41	2.98	1.4	11.16	19.81	58.9	56.05	78.45	77.53	78.97	72.98
Total Debt/Total Assets (%)	10.77	255.54	6.97	2.56	1.09	3.95	7.05	41.41	37.39	60.4	58.98	51.65	49.18
Net Debt to Equity	-117.84	-92.91	-104.48	-110.5	-112.62	-147.55	-181.31	44.6	31.32	270.61	219.12	341.69	191.62
Net Debt/Capital (%)	660.44	-1,310.25	2,331.69	1,052	892.21	310.31	259.9	29.79	23.09	72.2	67.89	76.84	65.3
EBITDA	-16	-17	-27	-93	-75	90	-8	118	91	172	316	336	405
EBITDA-CapEx	-16	-17	-27	-96	-76	66	-15	-256	89	171	316	334	403
Operating Income (Loss)	-16	-18	-27	-94	-75	-21	-24	56	22	33	167	167	178

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.88	0.16	11.35	5.99	3.77	0.78	0.84	0.73	0.67	0.4	0.68	0.32	0.88
Current Ratio	3.16	0.43	11.49	6.2	4.24	1.26	1.27	1.16	1.13	0.97	1.17	0.95	1.57
Quick Ratio	2.88	0.16	11.35	6.07	4.09	1.19	1.2	1.08	1.05	0.82	1.07	0.77	1.36
CFO/Avg Current Liab	- -	-2.75	-2.29	-4.41	-2.35	1.54	0.14	0.43	0.4	0.35	0.62	0.42	0.69
Common Equity/Total Assets	-755.2	-1,755.36	87.06	83.27	76.77	31.45	28.54	28.89	29.32	16.59	17.09	13.76	18.21
Long-Term Debt/Equity (%)	11.47	- -	4.87	1.1	- -	10.76	19.56	117.38	103.28	280	250.71	346.72	260.03
Long-Term Debt/Capital (%)	9.76	889.43	4.51	1.06	- -	9.56	15.69	48.24	45.4	60.35	56.34	72.92	70.26
Long-Term Debt/Total Assets (%)	7.08	133.85	4.24	0.91	- -	3.38	5.58	33.92	30.28	46.47	42.85	47.69	47.35
Total Debt/Equity (%)	17.43	-106.26	8.01	3.07	1.42	12.56	24.7	143.3	127.51	363.97	345.02	375.5	270.11
Total Debt/Capital (%)	14.84	1,698.04	7.41	2.98	1.4	11.16	19.81	58.9	56.05	78.45	77.53	78.97	72.98
Total Debt/Total Assets (%)	10.77	255.54	6.97	2.56	1.09	3.95	7.05	41.41	37.39	60.4	58.98	51.65	49.18
CFO/Total Liabilities	-478.85	-103.55	-170.54	-276.86	-212.84	84.84	12.69	20.52	21.17	12.69	28.99	14.29	24.3
CFO/CapEx	-80.24	-2,243.38	-59.58	-25.21	-67.69	6.96	4.32	0.25	53.27	76.59	595.98	124.08	189.27
Altman's Z-Score	-17.59	-40.84	25.39	7.23	7.73	0.9	1.1	1.15	0.85	0.83	2.13	1.89	2.47

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	1.61	4.71	6.38	3.93	3.97	2.93	3.21	3.13	3.09	3.55
Days Sales Outstanding	- -	- -	- -	227.09	77.53	57.22	92.82	91.99	124.69	113.67	116.77	117.94	102.84
Inventory Turnover	- -	- -	- -	0.32	1.66	34.41	22.18	10.31	7.65	7.96	6.1	7.49	8.3
Days Inventory Outstanding	- -	- -	- -	1,127.56	220.05	10.61	16.45	35.41	47.71	45.83	59.8	48.76	43.98
Accounts Payable Turnover	- -	- -	- -	0.24	0.42	19.25	21.25	16.74	18.03	73.81	37.16	40.76	44.22
Accounts Payable Turnover Days	- -	- -	- -	1,509.06	872.95	18.96	17.17	21.8	20.25	4.94	9.82	8.95	8.25
Cash Conversion Cycle	- -	- -	- -	-154.41	-575.36	48.87	92.1	105.6	152.15	154.55	166.75	157.74	138.57
Inventory to Cash Days	- -	- -	- -	-900.47	-142.52	46.61	76.36	56.59	76.97	67.84	56.98	69.18	58.86
Inventories	- -	- -	- -	1	2	8	10	16	17	47	32	36	41
Raw Materials	- -	- -	- -	- -	1	- -	1	4	4	6	10	- -	- -
Work In Process	- -	- -	- -	- -	- -	1	1	1	1	25	7	- -	- -
Finished Goods	- -	- -	- -	1	1	7	7	11	13	16	15	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	36	41

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	570	457	605	571	693	693	629	785	981	901	1,468
- Cash & Cash Equivalents	8	2	96	153	119	147	170	174	186	174	239	71	231
+ Preferred Equity and Hybrid Capital	74	77	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	13	7	4	1	12	22	267	259	709	674	859	815
Enterprise Value	67	88	481	308	488	436	545	786	701	1,321	1,345	1,597	1,896
Total Capital	7	1	92	139	106	103	109	453	462	904	870	1,088	1,117
Total Debt/Capital (%)	14.84	1,698.04	7.41	2.98	1.4	11.16	19.81	58.9	56.05	78.45	77.53	78.97	72.98
Total Debt / EV	0.01	0.15	0.01	0.01	- -	0.03	0.04	0.34	0.37	0.54	0.5	0.54	0.43
EV/Sales	- -	- -	- -	180.08	17.13	1.55	1.84	2.53	2.53	2.85	2.37	2.53	2.43
EV/EBITDA	- -	- -	- -	- -	- -	4.83	- -	6.67	7.69	7.67	4.25	4.75	4.69
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	13.97	31.57	39.64	8.05	9.57	10.63
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	2.3	18.98	6.44	- -	7.38	4.1	6.22	4.92
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	2.04	15.5	1.59	- -	7.31	4.1	6.18	4.9
Diluted Market Cap	- -	- -	372	378	559	566	688	704	767	785	1,286	1,158	1,838
Diluted Enterprise Value	67	88	284	229	441	431	540	797	839	1,320	1,722	1,947	2,422
EV per Share	3.41	4.49	23.21	10.49	14.88	13.11	16.17	22.7	20.83	39.02	42.19	50.8	59.8
TTM Sales	- -	- -	- -	2	28	280	297	310	277	464	567	631	781
TTM EBITDA	-16	-17	-27	-93	-75	90	-8	118	91	172	316	336	405
TTM Operating Income	-16	-18	-27	-94	-75	-21	-24	56	22	33	167	167	178
TTM Cash Flow to Firm	-16	-18	-21	-75	-67	190	29	122	-342	179	328	257	385
TTM Free Cash Flow to Firm	-16	-18	-21	-72	-66	214	35	496	-340	181	328	259	387

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-17.56	-5.24	-8.46	2.92	20.12	1.51	7.27	6.24	4.67	5.6	5.55
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	13.97	31.57	39.64	8.05	9.57	10.63
Enterprise Value	67	88	481	308	488	436	545	786	701	1,321	1,345	1,597	1,896
Low Price	- -	- -	11.92	8.24	7.37	13.7	10.01	13	17.22	14.04	20.83	28.47	23.23
EV/Sales	- -	- -	- -	180.08	17.13	1.55	1.84	2.53	2.53	2.85	2.37	2.53	2.43
EV/EBITDA	- -	- -	- -	- -	- -	4.83	- -	6.67	7.69	7.67	4.25	4.75	4.69
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	25.76	9.13	- -	21.57	13.36	23.35
Price/Earnings Average	- -	- -	-12.87	-4.06	-5.06	-17.52	-21.13	25	10.73	-24.87	17	16.14	17.16
Price/Earnings High	- -	- -	-20.68	-7.33	-8.46	-25.18	-32.8	32.91	13.15	-32.96	21.81	19.73	25.61
Price/Earnings Low	- -	- -	-8.06	-2.12	-2.98	-11.54	-14.74	16.72	8.41	-19	14.6	13.28	11.72
Price/Book Value	- -	- -	6.7	3.39	5.81	6.24	7.93	3.73	3.1	4.03	5.02	3.94	4.87
Price/Book Value Average	- -	- -	4.64	3.43	3.94	7.56	5.53	3.62	3.64	3.19	3.96	4.75	3.58
Price/Book Value High	- -	- -	7.45	6.2	6.59	10.86	8.58	4.76	4.46	4.23	5.07	5.81	5.34
Price/Book Value Low	- -	- -	2.91	1.79	2.32	4.98	3.86	2.42	2.86	2.44	3.4	3.91	2.44
Price/Tangible Book Value	- -	- -	6.7	3.44	5.81	12.07	11.96	-4.63	-9.56	-1.55	-2.72	-1.09	-2.86
Price/Tangible Book Value Average	- -	- -	4.64	3.49	3.94	14.62	8.34	-4.49	-11.24	-1.23	-2.15	-1.32	-2.1
Price/Tangible Book Value High	- -	- -	7.45	6.29	6.59	21.02	12.95	-5.91	-13.76	-1.63	-2.75	-1.61	-3.13
Price/Tangible Book Value Low	- -	- -	2.91	1.82	2.32	9.63	5.82	-3	-8.81	-0.94	-1.84	-1.09	-1.43
Price/Sales	- -	- -	- -	220.79	19.62	2.02	2.32	2.22	2.36	1.69	1.83	1.46	1.88
Price/Sales Average	- -	- -	- -	223.58	13.3	2.44	1.62	2.16	2.77	1.34	1.44	1.77	1.38
Price/Sales High	- -	- -	- -	403.72	22.23	3.51	2.51	2.84	3.4	1.78	1.85	2.16	2.06
Price/Sales Low	- -	- -	- -	116.85	7.83	1.61	1.13	1.44	2.17	1.02	1.24	1.46	0.94
Price/Cash Flow	- -	- -	-17.27	-5.03	-8.34	3.34	24.78	7.34	6.3	6.32	3.78	4.51	4.46
Price/Cash Flow Average	- -	- -	-11.95	-5.1	-5.65	4.05	17.28	7.12	7.41	5.01	2.98	5.45	3.28
Price/Cash Flow High	- -	- -	-19.2	-9.2	-9.45	5.82	26.83	9.37	9.08	6.63	3.82	6.66	4.89
Price/Cash Flow Low	- -	- -	-7.48	-2.66	-3.33	2.67	12.05	4.76	5.81	3.82	2.56	4.48	2.24
Price/Free Cash Flow Average	- -	- -	-12.15	-5.31	-5.74	3.54	14.03	1.46	8.55	4.94	3.68	6.77	4.08
Price/Free Cash Flow High	- -	- -	-19.53	-9.58	-9.59	5.09	21.78	1.92	10.47	6.55	4.73	8.27	6.09
Price/Free Cash Flow Low	- -	- -	-7.61	-2.77	-3.38	2.33	9.79	0.98	6.7	3.77	3.16	5.57	2.79
EV/Sales Average	- -	- -	- -	183.46	10.29	1.99	1.13	2.47	2.93	2.5	2.13	2.97	2.13
EV/Sales High	- -	- -	- -	401.47	19.96	3.07	2.03	3.16	3.53	2.93	2.52	3.35	2.81
EV/Sales Low	- -	- -	- -	54.28	4.37	1.14	0.64	1.75	2.35	2.18	1.94	2.67	1.69
EV/EBITDA Average	-4.24	-5.06	-11.43	-3.36	-3.91	6.17	-40.53	6.5	8.91	6.72	3.82	5.58	4.11
EV/EBITDA High	-4.24	-5.06	-20.4	-7.35	-7.59	9.53	-72.83	8.31	10.73	7.9	4.51	6.3	5.42
EV/EBITDA Low	-4.24	-5.06	-5.92	-0.99	-1.66	3.55	-22.83	4.61	7.15	5.87	3.48	5.01	3.26
EV/EBIT Average	-4.19	-5.01	-11.36	-3.34	-3.88	-26.92	-14.1	13.61	36.55	34.74	7.24	11.24	9.31
EV/EBIT High	-4.19	-5.01	-20.27	-7.3	-7.53	-41.55	-25.35	17.4	44.04	40.82	8.55	12.69	12.29
EV/EBIT Low	-4.19	-5.01	-5.88	-0.99	-1.65	-15.5	-7.95	9.65	29.36	30.33	6.58	10.08	7.4
Last Price	- -	- -	27.5	15.57	18.46	17.17	20.58	20.03	18.68	23.2	30.78	28.65	46.3
High Price	- -	- -	30.58	28.47	20.92	29.9	22.28	25.59	26.91	24.36	31.12	42.29	50.79
Enterprise Value Average	67	88	306	314	293	557	335	765	812	1,158	1,209	1,877	1,662
Enterprise Value High	67	88	545	687	568	860	602	978	978	1,360	1,427	2,118	2,194
Enterprise Value Low	67	88	158	93	124	321	189	542	652	1,011	1,099	1,684	1,320

Shares Outstanding	20	20	21	29	33	33	34	35	34	34	32	31	32
Diluted Weighted Avg Shares	7	7	14	24	30	33	33	35	41	34	42	40	40
Basic Weighted Avg Shares	7	7	14	24	30	33	33	34	35	34	34	32	32
Revenue per Share	- -	- -	- -	0.07	0.94	8.51	8.87	9.01	7.92	13.71	16.8	19.57	24.62
EBITDA per Share	-2.12	-2.34	-1.97	-3.85	-2.47	2.74	-0.25	3.42	2.61	5.09	9.37	10.42	12.76
Operating Income per Share	-2.15	-2.36	-1.99	-3.88	-2.49	-0.63	-0.71	1.63	0.64	0.98	4.95	5.17	5.63
Basic EPS, GAAP	-2.56	-2.84	-1.48	-3.88	-2.47	-1.19	-0.68	0.78	2.05	-0.74	1.43	2.14	1.98
Basic EPS from Cont Ops	-2.17	-2.4	-2.01	-3.88	-2.47	-1.19	-0.68	0.78	2.05	-0.74	1.43	2.14	1.98
Diluted EPS, GAAP	-2.56	-2.84	-1.48	-3.88	-2.47	-1.19	-0.68	0.76	1.74	-0.74	1.15	1.71	1.58
Diluted EPS from Cont Ops	-2.17	-2.4	-2.01	-3.88	-2.47	-1.19	-0.68	0.76	1.74	-0.74	1.15	1.71	1.58
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-2.21	-2.4	-1.59	-3.09	-2.21	5.14	0.83	2.73	2.96	3.67	8.14	6.35	10.39
Free Cash Flow per Basic Share	-2.24	-2.4	-1.62	-3.22	-2.25	4.4	0.64	-8.13	2.91	3.62	8.13	6.3	10.33
Cash & Equivalents per Share	0.38	0.08	4.61	5.22	3.62	4.41	5.05	5.03	5.54	5.13	9.74	5.18	12.2
Book Value per Share	-3.46	-4.53	4.1	4.59	3.18	2.75	2.6	5.37	6.03	5.76	6.13	7.28	9.51
Tangible Book Value per Share	-3.46	-4.53	4.1	4.52	3.18	1.42	1.72	-4.33	-1.95	-14.96	-11.3	-26.24	-16.2

Collegium Pharmaceutical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)